Ebrantil

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1977-2012
012319772012

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
The developing callus requires sufficient oxygen and substrate supply. Despite the importance of these processes, we have limited… (More)
  • figure 1
  • figure 2
  • table 1
  • table 4
  • table 5
Is this relevant?
1990
1990
In 10 patients on chronic haemodialysis treatment for terminal renal failure with hypertension urapidil (Ebrantil) was given in… (More)
Is this relevant?
1986
1986
Ebrantil has been added to the beta-blockers and/or diuretics in the treatment of 32 patients with moderate and severe… (More)
Is this relevant?
1985
1985
Urapidil (Ebrantil) is a new antihypertensive agent exerting central and peripheral action which is recognized for the treatment… (More)
Is this relevant?
1983
1983
Changes of contractility and oxygen metabolism following the administration of urapidil (Ebrantil) are described. Investigations… (More)
Is this relevant?
1982
1982
The influence of Ebrantil on serum electrolytes, lipids, and lipoproteins was studied in 8 normotensives and 10 hypertensives… (More)
Is this relevant?
1981
1981
The vasodilating effect of 6-(3-[4-(o-methoxy-phenyl)-piperazin-1-yl]-propylamino)-1,3-dimethyluracil (urapidil, Ebrantil) and… (More)
Is this relevant?
1977
1977
The acute toxicity of 6-(3-[4-(o-methoxyphenyl)-1-piperazinyl-propylamino)-1,3-dimethyluracil (urapidil, Ebrantil) was tested in… (More)
Is this relevant?
1977
1977
6-(3-[4-(o-Methoxyphenyl)-1-piperazinyl]-propylamino)-1,3-dimethyluracil (Urapidil, Ebrantil) is a new antihypertensive agent… (More)
Is this relevant?